Focus: Shoulder Innovations is a public biotechnology company specializing in shoulder replacement systems, a medical device/orthopedic focus within the biotech space. The company operates at modest scale with $32M in revenue and a focus on shoulder arthroplasty solutions.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Stable — net +2 jobs in 30d
3 added, 1 removed. Backfill posture.
Early-stage orthopedic play with public equity but fragile financials; suitable only for risk-tolerant professionals seeking device-space expertise in a potentially unstable environment.
Registry initiative supporting shoulder replacement system development; non-drug, registry-based asset with limited commercial visibility.
Help build intelligence for Shoulder Innovations
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Shoulder Innovations's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles